Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995

AIDS

Volumn 12, Issue 15, 1998, Pages 2059-2066

  Broers, Barbara ^a   Junet, Christian ^b   Bourquin, Michel ^b   Déglon, Jean Jacques ^b   Perrin, Luc ^a   Hirschel, Bernard ^a,c  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b Fondation Phenix   (Switzerland)

^c Div de Maladies Infectieuses   (Switzerland)

Author keywords

Drug user; Hepatitis B; Hepatitis C; HIV; Incidence; Methadone maintenance; Prevalence; Switzerland

Indexed keywords

METHADONE;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG ABUSE; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; SWITZERLAND;

EID: 0032558805     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199815000-00018     Document Type: Article

References (26)

1. Hahn RA, Onorato IM, Jones TS, Dougherty J: Prevalence of HIV infection among intravenous drug users in the United States. [Review] J Am Med Assoc 1989, 261:2677-2684.
2. des Jarlais DC, Friedman SR, Choopanya K, Vanichseni S, Ward TP: International epidemiology of HIV and AIDS among injecting drug users [editorial]. AIDS 1992, 6:1053-1068.
3. des Jarlais DC: The first and second decades of AIDS among injecting drug users. [Review] Br J Addiction 1992, 87:347-353.
4. Brettle R: HIV and harm reduction for injection drug users (editorial). AIDS 1991, 5:125-136.
5. Booth RE, Watters J: How effective are risk-reduction interventions targeting injecting drug users? AIDS 1994, 8:1515-1524.
6. Moss AR, Vranizan K, Gorter R, Bacchetti P, Watters J, Osmond D: HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS 1998, 8:223-265.
7. Dubois-Arber F, Jeannin A, Meystre-Agustoni G, Paccaud F: Evaluation de la stratégie de prévention du sida en Suisse. Quatrième rapport de synthèse 1991-1992. 1993, Cah Rech Doc No. 82.
8. Lowinson HJ, Ruiz P, Millman RB, Langrod JG, Fisher MG (Eds): Substance Abuse: A Comprehensive Texthook 2nd edn. Baltimore, MD: Williams & Wilkins, 1992.
9. Mino A: Evolution de la politique de soins en matière de toxicomanie: la réduction des risques. Cah Médico-sociaux 1994, 38:131-141.
10. Kitayaporn D, Uneklabh C, Weniger BC, et al.: HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS 1994, 8:1443-1450.
11. Nelson KE: The epidemiology of HIV infection among injecting drug users and other risk populations in Thailand (editorial comment). AIDS 1994, 8:1499-1500.
12. Breslow NE, Day NE: Statistical Methods in Cancer Research, Volume 2: Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research in Cancer 1987:70 (Table 2.10).
13. Kleinbaum DG, Kupper LL, Morgenstern H: Statistical inferences about effect measures: simple analysis. In Epidemiologic Research, Principles and Quantitative Methods. New York: Van Nostrand Reinhold, 1982:284-288.
14. Ross MW, Stowe A, Wodak A, Miller ME, Gold J: A comparison of drug use and HIV infection risk behaviour between injecting drug users currently in treatment, previously in treatment, and never in treatment. J Acqr Immune Def Syndr 1993, 6:518-528.
15. McCusker J, Koblin B, Lewis BF, Sullivan J: Demographic characteristics, risk behaviors, and HIV seroprevalence among intravenous drug users by site of contact: results from a community-wide HIV surveillance project. Am J Public Health 1990, 80:1062-1067.
16. Robert CF, Déglon JJ, Wintsch J, et al.: Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV-infection, 1980-1989. AIDS 1990, 4:657-660.
17. Thomé F, Broers B, Junet C, Mino A, Perrin L, Hirschel B: Le déclin d'une épidémie: Le VIH parmi les toxicomanes à Genève, 1988-1994. Presse Méd 1995, 24:1099-1102.
18. Broers B: Méthadone et SIDA. Méd Hyg 1994, 2162-2164.
19. van Ameijden EJ, van den Hoek JAR, Coutinho RA: Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am J Public Health 1994, 84:275-281.
20. des Jarlais DC, Friedman SR, Friedmann P, et al.: HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS 1995, 9:611-617.
21. Marmor M, Titus S, Wolfe H, et al.: Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs. AIDS Res Hum Retroviruses 1994, 10:Suppl 2:S207-13.
22. des Jarlais DC, Abdul-Quader A, Tross S: The next problem: maintenance of AIDS risk reduction among intravenous drug users. Int J Addict 1991, 26:1279-1292.
23. Nicolosi A, Molinari S, Musicco M, Saracco A, Ziliani N, Lazzarin A: Positive modification of injecting behavior among intravenous heroin users from Milan and northern Italy 1987-1989. NISDA Study. Br J Addict 1991, 86:91-102.
24. Hunter GM, Donoghoe MC, Stimson GV, Rhodes T, Chalmers CP: Changes in injecting risk behaviour of injecting drug users in London, 1990-1993. AIDS 1995, 9:493-501.
25. Siddiqui NS, Brown LS, Jr., Meyer TJ, Gonzalez V: Decline in HIV-1 seroprevalence and low seroconversion rate among injecting drug users at a methadone maintenance program in New York City. J Psychoactive Drugs 1993, 25:245-250.
26. Stimson GV: AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. Soc Sci Med 1995, 41:699-716.